Analysts Are Gushing Over Under Armour, Inc. (UA), Sage Therapeutics, Inc. (SAGE)

Under Armour, Inc. (NYSE:UA) last session’s volume of 5.01 million shares was higher than its average volume of 3.91 million shares. The stock, after opening at $14.6, hit $14.65 through the close by scoring 0%.

Under Armour, Inc. (UA) Analyst Opinion

Under Armour, Inc. has a consensus hold rating from 32 Wall Street analysts, and the number of shares currently sold short amount to at least 9.77% of shares outstanding. The stock sank -2.72% last month and is down -41.8 this year. Wall Street is only getting more bearish on the stock, with 6 of analysts who cover UA having a buy-equivalent rating. Analysts have placed a $20 price target on Under Armour, Inc., suggesting a 36.52% gain from recent close. It’s currently trading about -50.39% below its 52-week high.

Under Armour, Inc. Earnings Surprise

Under Armour, Inc. (UA) surprised the stock market in its last reported earnings when it earned -$0.03 a piece versus the consensus-estimated -$0.06. Its revenue totaled $1.08 billion down -3.6% from the previous quarter.

Under Armour, Inc. (NYSE:UA) Intraday View

This stock (UA) is ahead of its 52-week low with 2.52%. Its last month’s stock price volatility remained 4.2% which for the week stands at 2.72%. The share price has moved backward from its 20 days moving average, trading at a distance of -3.23% and stays -5.45% away from its 50 days moving average. Over the last five days, shares have faced -2.46% losses and now is down -19.77% since hitting its 200-day moving average of $17.47. Under Armour, Inc. (UA) has made its way to a 12-month decline of -46.65%.

Turning to Sage Therapeutics, Inc. (NASDAQ:SAGE), its shares were trading at $60.72 a retreat of $-0.91, on the trading floor. The stock, after opening at $61.46, touched a high of $61.74 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.7. Sage Therapeutics, Inc. has 6 buy ratings, 2 holds and 0 sells even after the stock tumbled -33.13% from its high of $ 90.80 to a $2.25 billion market value through last close.

Sage Therapeutics, Inc. (NASDAQ:SAGE) Intraday Trading

The counter witnessed a trading volume of 0.42 million shares versus an average volume of 0.56 million shares during last trading session. Its last month’s stock price volatility remained 3.39% which for the week approaches 3.26%. The lowest price the stock reached in the last trading day was $59.61 and compares with the $38.30 52-week low. The stock recovered 58.54% since its low point and has performed 18.92% year-to-date.

Previous articleAnalyst Views On Top Movers In Recent Trade: Las Vegas Sands Corp. (LVS), Acceleron Pharma Inc. (XLRN)
Next articleAnalysts Are Gushing Over Under Armour, Inc. (UAA), Nektar Therapeutics (NKTR)